What it's for (Indications)
- Hydrochlorothiazide, a thiazide diuretic, is primarily indicated for the management of hypertension, either as a monotherapy or in combination with other antihypertensive agents.
- Its efficacy in reducing elevated blood pressure contributes to decreasing the risk of cardiovascular events, including stroke and myocardial infarction.
- Beyond its use in hypertension, hydrochlorothiazide is also prescribed for the treatment of edema associated with various conditions.
- These include congestive heart failure, hepatic cirrhosis with ascites, and renal dysfunction such as nephrotic syndrome, acute glomerulonephritis, or chronic renal failure.
- Furthermore, it is utilized for edema induced by corticosteroid and estrogen therapy.
- Off-label uses include the management of nephrogenic diabetes insipidus and reduction of recurrent calcium nephrolithiasis due to its effect on calcium excretion.
- The selection of hydrochlorothiazide for these indications is based on its established pharmacological profile and clinical efficacy.
Dosage Information
| Type | Guideline |
|---|---|
| Standard | The dosage of hydrochlorothiazide must be individualized based on the patient's condition, response to therapy, and renal function. For the management of hypertension, the usual adult dosage ranges from 12.5 mg to 50 mg administered once daily. Lower doses, such as 12.5 mg, are often effective in reducing blood pressure with a favorable side effect profile, particularly when used in combination therapies. For the treatment of edema, the typical initial adult dosage is 25 mg to 100 mg daily, given as a single dose or in divided doses. Some patients may respond to an intermittent dosage schedule, such as administration on alternate days or three to five days per week. Dosage adjustments are critical in patients with impaired renal function; for those with a creatinine clearance less than 30 mL/min, thiazide diuretics may be ineffective, and alternative diuretics may be necessary. Careful monitoring of electrolyte levels is imperative during dosage initiation and adjustments. |
Safety & Warnings
Common Side Effects
- Hydrochlorothiazide can cause a range of side effects, predominantly related to its diuretic and electrolyte-modulating actions.
- Common adverse effects include electrolyte imbalances such as hypokalemia (low potassium), hyponatremia (low sodium), hypomagnesemia (low magnesium), and hypercalcemia (high calcium), which necessitate regular monitoring.
- Metabolic disturbances like hyperglycemia (elevated blood glucose), hyperuricemia (elevated uric acid leading to gout exacerbations), and dyslipidemia (altered lipid profiles) are also frequently observed.
- Other common side effects include dizziness, lightheadedness, orthostatic hypotension (a drop in blood pressure upon standing), and photosensitivity reactions (increased sensitivity to sunlight).
- Less common but serious adverse events may include pancreatitis, blood dyscrasias (e.
- g.
- , thrombocytopenia, leukopenia, agranulocytosis), cholestatic jaundice, acute interstitial nephritis, and acute transient myopia with acute angle-closure glaucoma.
- Patients should be advised to report any concerning symptoms promptly.
Serious Warnings
- Black Box Warning: While hydrochlorothiazide does not carry a formal FDA Black Box Warning in the traditional sense, several serious warnings merit significant attention due to their potential for severe patient harm. Foremost among these is the risk of acute transient myopia and acute secondary angle-closure glaucoma, which can lead to permanent vision loss if not promptly recognized and treated. Symptoms typically include acute onset of decreased visual acuity or ocular pain and usually occur within hours to weeks of initiating therapy. Patients should be advised to seek immediate medical attention if these symptoms develop. Furthermore, long-term use of hydrochlorothiazide has been associated with an increased risk of non-melanoma skin cancer (basal cell carcinoma and squamous cell carcinoma). Patients should be advised to limit exposure to sunlight and UV rays and to regularly examine their skin for any new lesions or changes in existing ones, reporting any suspicious findings to their healthcare provider. Additionally, severe electrolyte disturbances, particularly profound hypokalemia and hyponatremia, can lead to serious cardiac arrhythmias, neurological complications, and even death. Regular monitoring of serum electrolytes is crucial to prevent these life-threatening events.
- Several critical warnings are associated with hydrochlorothiazide use.
- Patients receiving hydrochlorothiazide should be routinely monitored for electrolyte imbalances, particularly hypokalemia, hyponatremia, and hypomagnesemia, which can lead to serious cardiac arrhythmias or neurological complications.
- Caution is advised in patients with pre-existing renal impairment, as thiazides can exacerbate renal dysfunction or precipitate azotemia.
- In patients with hepatic impairment or progressive liver disease, hydrochlorothiazide should be used with extreme caution as it may precipitate hepatic coma.
- As a sulfonamide derivative, hydrochlorothiazide carries a risk of hypersensitivity reactions, ranging from rash to more severe anaphylactic responses, especially in patients with a history of sulfonamide allergy.
- It can also cause acute transient myopia and acute secondary angle-closure glaucoma, requiring immediate discontinuation of the drug and medical attention.
- Thiazides may activate or exacerbate systemic lupus erythematosus.
- Patients with diabetes mellitus should be monitored closely for hyperglycemia, and those with hyperuricemia or a history of gout may experience exacerbations.
How it Works (Mechanism of Action)
Hydrochlorothiazide exerts its pharmacological effects primarily by inhibiting the sodium-chloride cotransporter (NCC) in the apical membrane of the epithelial cells in the distal convoluted tubule (DCT) of the nephron. This inhibition prevents the reabsorption of approximately 5-10% of filtered sodium and chloride, leading to increased excretion of these ions and water. Concomitantly, hydrochlorothiazide also increases the urinary excretion of potassium and magnesium, while paradoxically decreasing the excretion of calcium. The acute antihypertensive effect is thought to be mediated by a reduction in plasma volume and cardiac output. However, the long-term antihypertensive effect is attributed more to a decrease in total peripheral vascular resistance, possibly due to a direct vasodilatory effect or a reduction in sodium content within vascular smooth muscle cells, leading to decreased vascular responsiveness to endogenous vasoconstrictors. This dual action contributes to its efficacy in managing hypertension and edema.
Commercial Brands (Alternatives)
No other brands found for this formula.